A) Incidence of De Novo, Secondary, and Therapy-Related Acute Myeloid... | Download Scientific Diagram
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1 - Modern Pathology
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study | Blood Cancer Journal
Haematologica August 2021
Genes | Free Full-Text | Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
Acute Myeloid Leukemia | Oncohema Key
Biology of secondary leukemia
Outcome of patients with either de novo or secondary AML after alloSCT... | Download Scientific Diagram
AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics | Leukemia
Diagnosis and treatment of therapy-related acute myeloid leukemia - ScienceDirect
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults | Blood Cancer Journal
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
Secondary acute myeloid leukemia
Mutational variation in de-novo and secondary acute myeloid Leukemia.... | Download Scientific Diagram
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia
Frontiers | Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
Recurrent mutation groups in de novo AML. Genes recurrently mutated in... | Download Scientific Diagram
Venetoclax plus intensive induction chemotherapy safe for fit, older patients with AML
Secondary vs de novo acute myeloid leukemia
Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst - ScienceDirect
